Research Papers

14 of 689 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
Caroppo P; Habert MO; Durrleman S; Funkiewiez A; Perlbarg V; Hahn V; Bertin H; Gaubert M; Routier A; Hannequin D; Deramecourt V; Pasquier F; Rivaud-Pechoux S; Vercelletto M; Edouart G; Valabregue R; Lejeune P; Didic M; Corvol JC; Benali H; Lehericy S; Dubois B; Colliot O; Brice A; Le Ber I; Predict-PGRN study group.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Effects of Low Amyloid-β (Aβ) Concentration on Aβ1-42 Oligomers Binding and GluN2B Membrane Expression.
Gilson V; Mbebi-Liegeois C; Sellal F; de Barry J.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Reduced Incidence of Dementia in Solid Organ Transplant Patients Treated with Calcineurin Inhibitors.
Taglialatela G; Rastellini C; Cicalese L.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.
Voyle N; Baker D; Burnham SC; Covin A; Zhang Z; Sangurdekar DP; Tan Hehir CA; Bazenet C; Lovestone S; Kiddle S; Dobson RJ; AIBL research group.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Sen…
Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Calmodulin Binding Proteins and Alzheimer's Disease.
O'Day DH; Eshak K; Myre MA.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Inflammation Combined with Ischemia Produces Myelin Injury and Plaque-Like Aggregates of Myelin, Amyloid-β and AβPP in …
Zhan X; Cox C; Ander BP; Liu D; Stamova B; Jin LW; Jickling GC; Sharp FR.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
Di Marco LY; Farkas E; Martin C; Venneri A; Frangi AF.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
MTRNR2L12: A Candidate Blood Marker of Early Alzheimer's Disease-Like Dementia in Adults with Down Syndrome.
Bik-Multanowski M; Pietrzyk JJ; Midro A.
J Alzheimers Dis (Unknown)
Published: 2015
3/6 Transparent
Data Funding Declared
Serum leptin and risk of cognitive decline in elderly italians.
Littlejohns TJ; Kos K; Henley WE; Cherubini A; Ferrucci L; Lang IA; Langa KM; Melzer D; Llewellyn DJ.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
A phenotype of atypical apraxia of speech in a family carrying SQSTM1 mutation.
Boutoleau-Bretonnière C; Camuzat A; Le Ber I; Bouya-Ahmed K; Guerreiro R; Deruet AL; Evrard C; Bras J; Lamy E; Auffray-Calvier E; Pallardy A; Hardy J; Brice A; Derkinderen P; Vercelletto M.
J Alzheimers Dis (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease.
Shinto L; Quinn J; Montine T; Dodge HH; Woodward W; Baldauf-Wagner S; Waichunas D; Bumgarner L; Bourdette D; Silbert L; Kaye J.
J Alzheimers Dis (Unknown)
Published: 2014
3/6 Transparent
Registered Funding Declared
Angiotensin converting enzyme inhibitors and the reduced risk of Alzheimer's disease in the absence of apolipoprotein E…
Qiu WQ; Mwamburi M; Besser LM; Zhu H; Li H; Wallack M; Phillips L; Qiao L; Budson AE; Stern R; Kowall N.
J Alzheimers Dis (Unknown)
Published: 2013
2/6 Transparent
Funding Declared
LDL phenotype in subjects with mild cognitive impairment and Alzheimer's disease.
Vikarunnessa S; Weiner MF; Vega GL.
J Alzheimers Dis (Unknown)
Published: 2013
2/6 Transparent
Funding Declared